XOMA Royalty Corporation - Depo (XOMAO): Financials
Trailing 12 months ended March 31, 2026
Income statement, cash flow and balance sheet figures for XOMA Royalty Corporation - Depo (XOMAO), read directly from the XBRL data the company files with the SEC. Over the trailing twelve months the company reported $18.7M of revenue, up 93.5% year over year. Net income was $33.8M, or $1.57 per diluted share.
15 fiscal years of history are available, back to 2011.
Frequently asked questions
How much revenue does XOMAO make?
XOMA Royalty Corporation - Depo reported $18.7M of revenue over the trailing twelve months, for the period ended March 31, 2026. That is up 93.5% from the same period a year earlier.
Is XOMAO profitable?
XOMA Royalty Corporation - Depo was profitable over the trailing twelve months, earning $33.8M of net income, a net margin of 181.1%.
Where does this financial data come from?
Every figure on this page is read from the company's own SEC 10-Q and 10-K filings. Nothing is estimated by a third party. Quarterly figures a company does not file separately (most commonly the fourth quarter) are derived by subtracting the reported year-to-date quarters from the full fiscal year, and are labelled as derived.
What is the difference between quarterly, annual and TTM?
Quarterly shows each three-month fiscal period on its own. Annual shows the full fiscal year as filed in the 10-K. TTM (trailing twelve months) sums the last four reported quarters, which is the most current annualised view between 10-K filings.